Le Lézard
Classified in: Health
Subject: HEALTH

Marijuana Victims' Association: Is Marijuana the New Thalidomide


VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 4, 2016) - Phocomelia (limb malformation) has been shown in testing(i) of THC marijuana in a similar preclinical model to that which revealed the teratogenicity of thalidomide.

The federal government is aware of serious marijuana harms; it must not be complicit in risking Canadian health, but must mitigate by placing marijuana products under a protective protocol similar to REVAID used for Thalidomide.

As the stewards of the country's human and financial resources, it is critical that government protect the public from potential irreversible harm and itself from litigation. Marijuana harm is not only possible but probable.

A Health Canada document cites 1,000 scientific references that substantiate the risks.

The June 2016 Government public consultation discussion paper fails to inform the public of the risks, specifically to the fetus and reproduction by males.

If thalidomide offered the "high" of pot would it be reasonable to legalizing it for recreational use?

(i)Ref: Reece AS, Hulse GK. Chromothripsis and epigenomics complete causality criteria for cannabis- and addiction-connected carcinogenicity, congenital toxicity and heritable genotoxicity. Mutat Res. 2016;789:15-25.

Contact Information:
Marijuana Victims' Association
Pamela McColl
SAM Canada
1-778 354 3551

These press releases may also interest you

at 12:06
Revolution Enterprises ("Revolution" or "Company"), a national leader in the cannabis industry, is pleased to announce the appointment of Mr. Tony Hunter and Mr. Jim Oliff to its Board of Directors. Mr. Hunter, former CEO of Tribune Publishing and...

at 12:04
Henry Schein, Inc. announced today that it ranks first in its category on the FORTUNE® "World's Most Admired Companies" list for 2019. This recognition by FORTUNE marks the 18th consecutive year that Henry Schein has been named to the overall list....

at 12:00
OrthogenRx, Inc., a medical device company focused on the development and commercialization of treatments for musculoskeletal conditions including osteoarthritis (OA) has announced the launch of TriVisc® (sodium hyaluronate) for the treatment of...

at 12:00
23andMe, Inc., the leading personal genetics company, today received FDA clearance for a genetic health risk report on a hereditary colorectal cancer syndrome. The clearance follows the FDA's authorization for 23andMe's...

at 11:57
Medline has been awarded a group purchasing agreement for General Urology with Premier Inc. Effective March 1st, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier...

at 11:45
The FDA-cleared Lipogems procedure restores crucial cushioning for damaged tissue. It can be administered in the doctor's office as a stand-alone option to major, invasive surgery. For patients suffering from multiple orthopedic issues, their own fat...



News published on 4 august 2016 at 10:03 and distributed by: